Mustang Bio Stock Forum

$Mustang Bio(MBIO.US)$ LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
Benzinga· 4 mins ago
The Australian-based biopharma company MindBio Therapeutics Corp. (CSE:MBIO) obtained regulatory approval for a series of clinical trials in women's health using its proprietary LSD drug, MB22001. The company said it is the only one in the world with regulatory approvals of the take-home use of this type of scheduled drug in ...

$Mustang Bio(MBIO.US)$
NEWS
Mustang Bio Announces Pricing of $4 Million Public Offering

$Mustang Bio(MBIO.US)$ MindBio Therapeutics Corp. (MBIO.CN) earlier on Wednesday said first dosing has begun in a Phase 2B randomised controlled clinical trial microdosing MB22001 in patients with Major Depressive Disorder.
The company has secured regulatory and ministerial approvals for MB22001 to be self-administered by participants in the community and at home. In this trial, patients with major depressive disorder (MDD) will undertake an eight-week regimen of MindBio's lead candidate d...

$Mustang Bio(MBIO.US)$ is it a good entry now?

$Mustang Bio(MBIO.US)$ Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

$Mustang Bio(MBIO.US)$ Just looked! Shorts are moving in on this HTB listed ticker!

$Mustang Bio(MBIO.US)$ Unfortunately, my entry could be better...
$Mustang Bio(MBIO.US)$

$Mustang Bio(MBIO.US)$ Phase 1 CAR T Cell Therapy Trial For Glioblastoma At City Of Hope, Demonstrates Clinical Activity Against Incurable Brain Tumors, The IL13Rα2-Targeting CAR T Cell Is Exclusively Licensed By Mustang Bio, A Fortress Biotech Company